T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I–bound peptide
暂无分享,去创建一个
Natalie A Borg | Ashley M Buckle | James McCluskey | James C Whisstock | Anthony W Purcell | Jamie Rossjohn | Lars Kjer-Nielsen | Lyudmila Kostenko | J. Whisstock | T. Beddoe | A. Buckle | J. McCluskey | J. Rossjohn | John J Miles | S. L. Silins | J. Burrows | S. Burrows | F. E. Tynan | L. Kjer-Nielsen | A. Purcell | M. Wilce | N. Borg | C. Clements | L. Kostenko | Fleur E Tynan | Travis Beddoe | Scott R Burrows | Jacqueline M Burrows | Craig S Clements | Sharon L Silins | Matthew C Wilce
[1] D. Wiley,et al. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. , 1998, Immunity.
[2] R. Kridel,et al. An Alternative Open Reading Frame of the Human Macrophage Colony-Stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-Infiltrating Cd8 T Lymphocytes , 2001, The Journal of experimental medicine.
[3] William S. Lane,et al. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.
[4] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database , 1999, Nucleic Acids Res..
[5] G W Butcher,et al. Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. , 2001, Immunity.
[6] A Sette,et al. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. , 1994, Journal of immunology.
[7] L R Pease,et al. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.
[8] Ian A Wilson,et al. The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.
[9] P. A. Peterson,et al. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.
[10] J. Wells,et al. A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Probst-Kepper,et al. Conformational Restraints and Flexibility of 14-Meric Peptides in Complex with HLA-B*35011 , 2004, The Journal of Immunology.
[12] L. K. Ely,et al. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition , 2005, Nature Immunology.
[13] William Arbuthnot Sir Lane,et al. A subset of HLA-B27 molecules contains peptides much longer than nonamers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Goldberg,et al. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. , 2002, Molecular immunology.
[15] P. Cresswell,et al. Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.
[16] J A Wells,et al. Dissecting the energetics of an antibody‐antigen interface by alanine shaving and molecular grafting , 1994, Protein science : a publication of the Protein Society.
[17] G. Cohen,et al. Interactions of protein antigens with antibodies. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] N. Papadopoulos,et al. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria. , 1999, Journal of immunology.
[19] G. Thomas,et al. Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis. , 1999, Trends in cell biology.
[20] Partho Ghosh,et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.
[21] M. Bonneville,et al. Gamma delta T cells. , 1990 .
[22] Bernard Malissen,et al. A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. , 2002, Immunity.
[23] J. Neefjes,et al. Peptide selection by MHC-encoded TAP transporters. , 1994, Current opinion in immunology.
[24] Mark M Davis,et al. T cell killing does not require the formation of a stable mature immunological synapse , 2004, Nature Immunology.
[25] D. Blaas,et al. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. , 1994, The EMBO journal.
[26] J. Sacchettini,et al. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] Bernard Malissen,et al. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule , 2000, Nature Immunology.
[28] D. Garboczi,et al. Shapes of MHC restriction. , 1999, Immunity.
[29] P. Anton van der Merwe,et al. CDR3 loop flexibility contributes to the degeneracy of TCR recognition , 2003, Nature Immunology.
[30] J. Claverie,et al. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response. , 1986, Annales de l'Institut Pasteur. Immunology.
[31] Mark M Davis,et al. How T cells 'see' antigen , 2005, Nature Immunology.
[32] K. Garcia,et al. Structural basis of T cell recognition. , 1999, Annual review of immunology.
[33] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[34] Simon J Davis,et al. Molecular interactions mediating T cell antigen recognition. , 2003, Annual review of immunology.
[35] H. Rammensee,et al. Peptides naturally presented by MHC class I molecules. , 1993, Annual review of immunology.
[36] Brian M. Baker,et al. Identification of a Crucial Energetic Footprint on the α1 Helix of Human Histocompatibility Leukocyte Antigen (Hla)-A2 That Provides Functional Interactions for Recognition by Tax Peptide/Hla-A2–Specific T Cell Receptors , 2001, The Journal of experimental medicine.
[37] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[38] A. Goldberg,et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8–9 residues , 2002, Nature Immunology.
[39] J. Whisstock,et al. A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity , 2003 .
[40] Vasso Apostolopoulos,et al. Structural Comparison of Allogeneic and Syngeneic T Cell Receptor–Peptide-Major Histocompatibility Complex Complexes , 2002, The Journal of experimental medicine.
[41] S. L. Silins,et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen , 1995, The Journal of experimental medicine.
[42] D. Wiley,et al. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.
[43] J. A. Payne,et al. Differential transport requirements of HLA and H-2 class I glycoproteins , 2004, Immunogenetics.
[44] Wendy J M van Zuylen,et al. Potent T cell response to a class I‐binding 13‐mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length , 2004, European journal of immunology.
[45] F. Ginhoux,et al. Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport1 , 2003, The Journal of Immunology.
[46] G N Murshudov,et al. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[47] David I Stuart,et al. A structural basis for immunodominant human T cell receptor recognition , 2003, Nature Immunology.
[48] James McCluskey,et al. A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition , 2003, The Journal of experimental medicine.
[49] K. Wucherpfennig,et al. Unconventional topology of self peptide–major histocompatibility complex binding by a human autoimmune T cell receptor , 2005, Nature Immunology.
[50] Randy J Read,et al. Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Rotation Functions Biological Crystallography Likelihood-enhanced Fast Rotation Functions , 2003 .
[51] J. Beck,et al. Strategic Mutations in the Class I Major Histocompatibility Complex HLA-A2 Independently Affect Both Peptide Binding and T Cell Receptor Recognition* , 2004, Journal of Biological Chemistry.
[52] Natalie A Borg,et al. High Resolution Structures of Highly Bulged Viral Epitopes Bound to Major Histocompatibility Complex Class I , 2005, Journal of Biological Chemistry.
[53] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[54] Mark M. Davis,et al. Two-step binding mechanism for T-cell receptor recognition of peptide–MHC , 2002, Nature.
[55] Morgan Huse,et al. Agonist/endogenous peptide–MHC heterodimers drive T cell activation and sensitivity , 2005, Nature.
[56] K. Christopher Garcia,et al. Structure of a γδ T Cell Receptor in Complex with the Nonclassical MHC T22 , 2005, Science.
[57] Mark M Davis,et al. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. , 2003, Molecular cell.
[58] J. McCluskey,et al. Identification of a dominant self‐ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex , 2002, FEBS letters.
[59] A. Smolyar,et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. , 1999, Science.
[60] Philip J Norris,et al. A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[61] N. Shastri,et al. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum , 2002, Nature.
[62] D. Lo,et al. Preferential expression of TCR V alpha regions in CD4/CD8 subsets: class discrimination or co-receptor recognition? , 1998, Immunology today.
[63] D. Wiley,et al. The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[64] R. Zinkernagel,et al. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.
[65] J. McCluskey,et al. The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state. , 2002, Acta crystallographica. Section D, Biological crystallography.
[66] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[67] Mark M. Davis,et al. Direct observation of ligand recognition by T cells , 2002, Nature.
[68] D. Hafler,et al. Conserved CDR3 Regions in T-Cell Receptor (TCR) CD8+T Cells That Recognize the Tax11-19/HLA-A*0201 Complex in a Subject Infected with Human T-Cell Leukemia Virus Type 1: Relationship of T-Cell Fine Specificity and Major Histocompatibility Complex/Peptide/TCR Crystal Structure , 2001, Journal of Virology.